Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-20T11:50:23.391Z Has data issue: false hasContentIssue false

Chapter 22 - Hormone replacement therapy and cancer

Published online by Cambridge University Press:  05 September 2015

By
Franco Guidozzi
Edited by
Nick Panay ,
Paula Briggs  and
Gab Kovacs
Nick Panay
Affiliation:
Queen Charlotte’s Hospital, London
Paula Briggs
Affiliation:
Sefton Community Sexual Health Service, Liverpool
Gab Kovacs
Affiliation:
Monash University, Victoria
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Managing the Menopause
21st Century Solutions
 , pp. 173 - 182
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anderson, GL, Chlebowski, RT, Aragaki, AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomized placebo controlled trial. Lancet Oncol 2012; 13: 476–86.CrossRefGoogle Scholar
Sturdee, DW. Endometrial safety and bleeding with HRT: what's new? Climacteric 2007; 10: 66–70.CrossRefGoogle ScholarPubMed
Auranen, A, Heitanen, S, Salmi, T, Grenman, S. Hormonal treatments and epithelial ovarian cancer risk. Int J Gynecol Cancer 2005; 15: 692–700.CrossRefGoogle ScholarPubMed
Gadducci, A, Biglia, N, Cosio, S, Sismondi, P, Gennazzani, AR. Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy. Gynecol Endocrinol 2010; 26: 568–77.CrossRefGoogle ScholarPubMed
Simon, MS, Chlebowski, RT, Wactawzki-Wende, J, et al. Estrogen plus progestin and colorectal cancer. Incidence and mortality. J Clin Oncol 2012; 30: 3983–90.CrossRefGoogle ScholarPubMed
Brinton, L, Schwartz, L, Spitz, MR, et al. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Causes Control 2012; 23: 487–96.CrossRefGoogle ScholarPubMed
Tang, JY, Spaunhurst, KM, Chlebowski, RT, et al. Menopausal hormone therapy and risk of melanoma and non-melanoma skin cancers. Women's Health Initiative Randomized Trials. J Natl Cancer Inst 2011; 103: 1469–75.CrossRefGoogle Scholar
Freedman, ND, Lacey, JV, Hollenbeck, AR, et al. The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer 2010; 116: 1572–81.CrossRefGoogle ScholarPubMed
Holmberg, L, Iverson, O-E, Rudenstam, CM, et al. on behalf of the HABITS Study Group. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Instit 2008; 100: 475–82.CrossRefGoogle Scholar
Fahlen, M, Fornander, T, Johansson, H, et al. Hormone replacement therapy after breast cancer: 10 years follow up of the Stockholm randomized trial. Eur J Cancer 2013; 49: 52–9.CrossRefGoogle Scholar
Kenenmans, P, Bundred, N, Foidart, J-M, et al. on behalf of the LIBERATE Study Group. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomized, non-inferiority trial. Lancet Oncol 2009; 10: 135–46.Google Scholar
Guidozzi, F. Hormone therapy in gynaecologic cancer survivors. Climacteric 2013; 16: 611–17.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×